Understanding APC - malecare.org

Degarelix Proves to be the Superior Hormone Deprivation Treatment (ADT) for Men with Advanced Prostate Cancer

Based on six recent retrospective analyses comparing the gonadotropin-releasing hormone (GnRH) antagonist degarelix against the traditional luteinizing hormone-releasing hormone (LHRH) agonists (i.e. Zoladex, Lupron etc.) men with advanced prostate cancer experienced improved disease control, fewer instances of urinary infections, and a lower risk of cardiovascular events. The six analyses compared data from randomized trials that [...]

By Malecare|2017-10-19T10:49:17-04:00November 5th, 2013|Advanced Prostate Cancer, Drugs & Treatments, Firmagon (degarelix), Hormone Therapy, Research, Uncategorized, Understanding APC|2 Comments

Bone Disease in Men with Prostate Cancer Needs Constant Monitoring

The number of cancer survivors is increasing, soon to be as many of 13 million of us in the world! Bones are often affected in cancer survivors, usually a result of bone metastases, or of anti-cancer therapies which can contribute to bone loss and fragility. Bone disease in cancer survivors can result both from the [...]

By Malecare|2013-11-04T20:25:00-05:00November 4th, 2013|Advanced Prostate Cancer, bisphosphonates, Bone Metastases, Bone Mineral Density, denosumab - Xgeva, Drugs & Treatments, General Information, Hormone Therapy, Quality of Life, Uncategorized, Understanding APC, Zometa|0 Comments

Caregiving -It Isn’t Easy

Becoming a full time 24/7 caregiver for someone with any chronic illness, including advanced prostate cancer is overwhelming. Most caregivers find that they stop their own personal activities, including those that give them personal pleasure. Caregiving means subverting personal needs in favor of the needs of the patient. This situation often leads to the [...]

By Malecare|2017-10-19T10:49:19-04:00November 1st, 2013|Advanced Prostate Cancer, End-Of-Life, How We Live, Our Caretakers, Uncategorized, Understanding APC|0 Comments

Why Xofigo is Superior to Other Radiopharmaceuticals for Advanced Prostate Cancer Treatment

We are in the fortunate position because the treatment of men with metastatic castration-resistant prostate cancer (mCRPC) continues to evolve as new agents with the ability to extend survival gain FDA approval. The most recently FDA approved treatment, the alpha emitting radiopharmaceutical radium-223 (Xofigo) was approved for men with bone metastatic prostate cancer. Most other [...]

By Malecare|2013-10-31T13:13:04-04:00October 31st, 2013|Advanced Prostate Cancer, Alpha Emitting Radio Therapy, Alpharadin (radium-223), Bone Metastases, Clinical Trials, Clinical Trials, Drugs & Treatments, radiopharmaceuticals, Uncategorized, Understanding APC, Xofigo|8 Comments

Positive Surgical Margins – Do They Really Matter and Do They Effect How Long You Are Going To Live?

Men who elect to have a radical prostatectomy (surgical treatment for prostate cancer) as their primary treatment often panic if they find out that they had positive surgical margins (PSMs). Positive surgical margins are an indication for the use of adjuvant radiotherapy. Despite this automatic response the association between PSMs and prostate cancer-specific mortality (CSM) [...]

By Malecare|2020-02-04T12:38:28-05:00October 30th, 2013|Advanced Prostate Cancer, General Information, Research, salvage therapy, Uncategorized, Understanding APC|0 Comments